Pds-cfsc.com

Pds-cfsc.com has Server used 208.43.88.227 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2004-07-15 (15 years, 228 days) and hosted in Chantilly United States, server ping response time 9 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Pds-cfsc keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Pds-ctsc-011
2 Pds-ctsc-021

Hosting Provider

Website: Pds-cfsc.com
Hostname: e3.58.2bd0.ip4.static.sl-reverse.com
Country:
Region: VA
City: Chantilly
Postal Code: 20151
Latitude: 38.9035987854
Longitude: -77.451202392578
Area Code: 703
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Tutuapp-app.com (5 seconds ago)

   » Jman2-0.com (6 seconds ago)

   » Beachbikes.net (20 seconds ago)

   » Ihsgroup.net (8 seconds ago)

   » Gektor.biz (23 seconds ago)

   » Ritagfineconsign.com (5 seconds ago)

   » Beachboundescapes.com (25 seconds ago)

   » On-coffee.com (6 seconds ago)

   » Tmckansas.com (16 seconds ago)

Results For Websites Listing

Found 43 Websites with content related to this domain, It is result after search with search engine

pds-cfsc.com - Sleep Specialists | Kissimmee, ST | Central

(5 day ago) For more than 30 years, Pulmonary Disease Specialists, PA has earned the confidence and trust of patients and their referring physicians in several counties throughout Central Florida. Our providers are currently participating in critical care programs at Florida Hospital Kissimmee and Osceola Regional Medical Center.

https://www.pds-cfsc.com/

DA: 16 PA: 16 MOZ Rank: 17

FollowMyHealth® Sign In

(6 day ago) Having trouble logging in? Try one of the recovery options below to get back into your account.

https://pds-cfsc.followmyhealth.com/patientaccess

DA: 27 PA: 14 MOZ Rank: 41

Contact Us - PULMONARYDISEASESPECIALISTS.COM

(12 day ago) Camille Mollica (407) 483-4667 [email protected] Billing Manager Iris Fernandez (407) 933-1221 x403 [email protected] Operations Manager Lee Perez (407) 933-1221 x411 [email protected] Research Director Margaret Bell (407) 624-4831 [email protected]

http://www.pulmonarydiseasespecialists.com/contact.html

DA: 35 PA: 13 MOZ Rank: 48

Evaluation of Efficacy and Safety of Pamrevlumab in

(5 day ago) This is a Phase 3, randomized, double-blind, placebo-controlled, multi-center trial to evaluate the efficacy and safety of pamrevlumab in subjects with idiopathic pulmonary fibrosis (IPF) over a 52 week period.

https://clinicaltrials.gov/ct2/show/NCT03955146

DA: 18 PA: 21 MOZ Rank: 39

FollowMyHealth® Sign In

(3 day ago) Having trouble logging in? Try resetting your password below or contact your administrator for help.

https://pds-cfsc.followmyhealth.com/Login/App/Dashboard?authproviders=0#!/default

DA: 27 PA: 20 MOZ Rank: 47

Pulmonary Disease Specialists - Health | 110 Park Pl Blvd

(19 day ago) Pulmonary Disease Specialists is a business providing services in the field of Health, . The business is located in 110 Park Pl Blvd, Davenport, FL 33837, USA. Their telephone number is +1 863-419-0104.

https://www.businessyab.com/explore/united_states/florida/polk_county/davenport/park_place_boulevard/110/pulmonary_disease_specialists.html

DA: 19 PA: 50 MOZ Rank: 50

Evaluation of Efficacy and Safety of Pamrevlumab in

(5 day ago) Search Results Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis Study Purpose This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in subjects with Idiopathic Pulmonary Fibrosis

https://trials.pulmonaryfibrosis.org/trials/NCT03955146

DA: 28 PA: 19 MOZ Rank: 47

A Phase 3 Adaptive Study to Evaluate the Safety and

(3 day ago) A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With PH Due to COPD - Full Text View.

https://clinicaltrials.gov/ct2/show/NCT03496623

DA: 18 PA: 21 MOZ Rank: 39

Recently Analyzed Sites